Human Immunodeficiency Virus 1 and Type I Interferons-Where Sex Makes a Difference

Area of Science:

• Immunology
• Virology
• Infectious Diseases

Background:

• The human immunodeficiency virus (HIV)-1 epidemic disproportionately affects women, particularly in sub-Saharan Africa.
• Sex-specific differences in HIV-1 disease progression are influenced by immunological factors, including sex hormones and X chromosome gene dosage.
• Type I interferons (IFNs) are crucial for controlling HIV-1, but their continuous stimulation in chronic infection can exacerbate immune activation, potentially more so in women.

Purpose of the Study:

• To review current knowledge on sex-specific differences in HIV-1 infection.
• To explore the roles of sex hormones and immunological pathways in differential HIV-1 outcomes.
• To understand the impact of immune activation and type I IFNs on HIV-1 progression in women versus men.

Main Methods:

• Literature review of recent findings on sex differences in HIV-1 infection.
• Analysis of immunological pathways modulated by sex hormones and X-linked genes.
• Examination of the role of type I interferons (IFNs) and immune activation in HIV-1 pathogenesis.

Main Results:

• Women exhibit lower HIV-1 viral loads early in infection but faster progression to AIDS at equivalent viremia levels compared to men.
• Elevated immune activation, potentially linked to continuous type I interferon stimulation, may be more pronounced in HIV-1-infected women.
• Steroid hormone signaling is implicated in regulating viral replication, contributing to observed sex differences in HIV-1 disease.

Conclusions:

• Sex-specific factors significantly impact HIV-1 infection dynamics and disease progression.
• Understanding these sex differences is crucial for developing targeted prevention and treatment strategies.
• Further research into hormonal and immunological sex differences can elucidate mechanisms driving differential HIV-1 outcomes.